BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uchida N, Takasaki K, Sakata Y, Nogami A, Oishi H, Watanabe T, Shindo T, Egashira N, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M, Nishimura R, Iwasaki K. Cholinergic involvement and synaptic dynamin 1 expression in Yokukansan-mediated improvement of spatial memory in a rat model of early Alzheimer's disease. Phytother Res 2013;27:966-72. [PMID: 22888033 DOI: 10.1002/ptr.4818] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Dong MY, Zhang Y, Jiang HQ, Ren WJ, Xu LC, Zhang YQ, Liu YH. Benzofuran derivatives with nerve growth factor-potentiating activity from Phellinus ribis. Nat Prod Res 2020;:1-8. [PMID: 32608259 DOI: 10.1080/14786419.2020.1786827] [Reference Citation Analysis]
2 Diling C, Yinrui G, Longkai Q, Xiaocui T, Yadi L, Xin Y, Guoyan H, Ou S, Tianqiao Y, Dongdong W, Yizhen X, Yang BB, Qingping W. Circular RNA NF1-419 enhances autophagy to ameliorate senile dementia by binding Dynamin-1 and Adaptor protein 2 B1 in AD-like mice. Aging (Albany NY) 2019;11:12002-31. [PMID: 31860870 DOI: 10.18632/aging.102529] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
3 Jeon SG, Song EJ, Lee D, Park J, Nam Y, Kim JI, Moon M. Traditional Oriental Medicines and Alzheimer's Disease. Aging Dis 2019;10:307-28. [PMID: 31435482 DOI: 10.14336/AD.2018.0328] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
4 Jang JH, Jung K, Kim JS, Jung I, Yoo H, Moon C. Potential Application of Yokukansan as a Remedy for Parkinson's Disease. Evid Based Complement Alternat Med 2018;2018:1875928. [PMID: 30671124 DOI: 10.1155/2018/1875928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kaushik R, Morkovin E, Schneeberg J, Confettura AD, Kreutz MR, Senkov O, Dityatev A. Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer's Disease. Front Aging Neurosci 2018;10:411. [PMID: 30631278 DOI: 10.3389/fnagi.2018.00411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Kalász H, Ojha S, Tekes K, Szőke É, Mohanraj R, Fahim M, Adeghate E, Adem A. Pharmacognostical Sources of Popular Medicine To Treat Alzheimer's Disease. Open Med Chem J 2018;12:23-35. [PMID: 29515678 DOI: 10.2174/1874104501812010023] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Nogami-hara A, Nagao M, Takasaki K, Egashira N, Fujikawa R, Kubota K, Watanabe T, Katsurabayashi S, Hatip FB, Hatip-al-khatib I, Iwasaki K. The Japanese Angelica acutiloba root and yokukansan increase hippocampal acetylcholine level, prevent apoptosis and improve memory in a rat model of repeated cerebral ischemia. Journal of Ethnopharmacology 2018;214:190-6. [DOI: 10.1016/j.jep.2017.12.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Kubota K, Fukue H, Sato H, Hashimoto K, Fujikane A, Moriyama H, Watanabe T, Katsurabayashi S, Kainuma M, Iwasaki K. The Traditional Japanese Herbal Medicine Hachimijiogan Elicits Neurite Outgrowth Effects in PC12 Cells and Improves Cognitive in AD Model Rats via Phosphorylation of CREB. Front Pharmacol 2017;8:850. [PMID: 29209220 DOI: 10.3389/fphar.2017.00850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
9 Mizoguchi K, Ikarashi Y. Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Front Pharmacol 2017;8:655. [PMID: 28979206 DOI: 10.3389/fphar.2017.00655] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
10 Mizoguchi K, Ikarashi Y. Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects. Front Pharmacol 2017;8:149. [PMID: 28377723 DOI: 10.3389/fphar.2017.00149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
11 Ikarashi Y, Mizoguchi K. Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients. Pharmacol Ther 2016;166:84-95. [PMID: 27373856 DOI: 10.1016/j.pharmthera.2016.06.018] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
12 Kangarlu-Haghighi K, Oryan S, Nasehi M, Zarrindast MR. The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA. EXCLI J 2015;14:613-26. [PMID: 26648818 DOI: 10.17179/excli2015-201] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Schrader M, Costello JL, Godinho LF, Azadi AS, Islinger M. Proliferation and fission of peroxisomes - An update. Biochim Biophys Acta 2016;1863:971-83. [PMID: 26409486 DOI: 10.1016/j.bbamcr.2015.09.024] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 11.0] [Reference Citation Analysis]
14 Okamoto H, Iyo M, Ueda K, Han C, Hirasaki Y, Namiki T. Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions. Neuropsychiatr Dis Treat. 2014;10:1727-1742. [PMID: 25246794 DOI: 10.2147/ndt.s65257] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
15 Yu CH, Ishii R, Yu SC, Takeda M. Yokukansan and its ingredients as possible treatment options for schizophrenia. Neuropsychiatr Dis Treat 2014;10:1629-34. [PMID: 25210456 DOI: 10.2147/NDT.S67607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Kubota K, Nogami A, Takasaki K, Katsurabayashi S, Mishima K, Fujiwara M, Iwasaki K. [Pharmacological study of the amerliorative effects of Yokukansan on memory impairment and the behavioral and psychological symptoms of dementia in AD models]. Nihon Yakurigaku Zasshi 2014;143:110-4. [PMID: 24614632 DOI: 10.1254/fpj.143.110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Liu Y, Nakamura T, Toyoshima T, Lu F, Sumitani K, Shinomiya A, Keep RF, Yamamoto T, Tamiya T, Itano T. Ameliorative effects of yokukansan on behavioral deficits in a gerbil model of global cerebral ischemia. Brain Res 2014;1543:300-7. [PMID: 24269335 DOI: 10.1016/j.brainres.2013.11.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]